Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome

Open access
Kałużna, Małgorzata, Czlapka-Matyasik, Magdalena, Kompf, Pola, Moczko, Jerzy, Wachowiak-Ochmańska, Katarzyna, Janicki, Adam, Samarzewska, Karolina, Ruchała, Marek, Ziemnicka, Katarzyna · 2022 · Therapeutic Advances in Endocrinology and Metabolism

Abstract

Background: Insulin resistance (IR) is common in women with polycystic ovary syndrome (PCOS). Metabolic syndrome (MS) involves IR, arterial hypertension, dyslipidemia, and visceral fat accumulation. Therefore, fatness indices and blood lipid ratios can be considered as screening markers for MS. Our study aimed to evaluate the predictive potential of selected indirect metabolic risk parameters to identify MS in PCOS. Methods: This cross-sectional study involved 596 women aged 18–40 years, including 404 PCOS patients diagnosed according to the Rotterdam criteria and 192 eumenorrheic controls (CON). Anthropometric and blood pressure measurements were taken, and blood samples were collected to assess glucose metabolism, lipid parameters, and selected hormone levels. Body mass index (BMI), waist-to-height ratio (WHtR), homeostasis model assessment for insulin resistance index (HOMA-IR), visceral adiposity index (VAI), lipid accumulation product (LAP), non-high-density lipoprotein cholesterol (non-HDL-C), and triglycerides-to-HDL cholesterol ratio (TG/HDL-C) were calculated. MS was assessed using the International Diabetes Federation (IDF) and the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) criteria. Results: MS prevalence was significantly higher in PCOS versus CON. Patients with both MS and PCOS had more unfavorable anthropometric, hormonal, and metabolic profiles versus those with neither MS nor PCOS and versus CON with MS. LAP, TG/HDL-C, VAI, and WHtR were the best markers and strongest indicators of MS in PCOS, and their cut-off values could be useful for early MS detection. MS risk in PCOS increased with elevated levels of these markers and was the highest when TG/HDL-C was used. Conclusions: LAP, TG/HDL-C, VAI, and WHtR are representative markers for MS assessment in PCOS. Their predictive power makes them excellent screening tools for internists and enables acquiring accurate diagnoses using fewer MS markers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/20420188211066699

Cites

Statistics

Figures

Figure 1. Adjusted ORs for MS in PCOS patients with high TG/HDL-C, LAP, WHtR, and VAI. LCI, lower 95% confidence interval; UCI, upper 95% confidence interval.
Figure 1. Adjusted ORs for MS in PCOS patients with high TG/HDL-C, LAP, WHtR, and VAI. LCI, lower 95% confidence interval; UCI, upper 95% confidence interval.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 55 · Cited by 32

Research works printed but not linked: 4

  1. Abruzzese GA, 2017, Horm Metab Res, 49, 23
  2. Guleken Z, 2021, J Med Physiol Biophys, 71, 5
  3. 10.1007/BF03401401 · doi:10.1007/bf03401401
  4. Borrayo G, 2018, Acta Endocrinol, 14, 261

Metadata

Authors
Kałużna, M., Czlapka-Matyasik, M., Kompf, P., Moczko, J., Wachowiak-Ochmańska, K., Janicki, A., Samarzewska, K., Ruchała, M., & Ziemnicka, K.
Affiliations
  • Poznan University of Medical Sciences (PL)
  • Department of Human Nutrition and Dietetics, Poznan University of Life Sciences, Poznan, Poland
  • Heliodor Swiecicki Clinical Hospital (PL)
Corresponding author
Kałużna, Małgorzata
Venue
Therapeutic Advances in Endocrinology and Metabolism
Published
2022-01
Volume
13
Pages
20420188211066699-20420188211066699
ISSN
  • 2042-0188 (ISSN-L)
  • 2042-0196
OpenAlex
W4206551005
Cited by
32
References
55
Citations by year
2026: 8 · 2025: 11 · 2024: 7 · 2023: 5 · 2022: 1
FWCI
5.06
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Endocrinology and Metabolism (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu (502-14-02221355-41164)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
polycystic ovary syndrome, metabolic syndrome, metabolic syndrome screening, lipid ratios, triglyceride to HDL cholesterol ratio, lipid accumulation product, visceral adiposity index, waist-to-height ratio, insulin resistance, obesity indices, women

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1177/20420188211066699
The paper
Kałużna, M., Czlapka-Matyasik, M., Kompf, P., Moczko, J., Wachowiak-Ochmańska, K., Janicki, A., Samarzewska, K., Ruchała, M., & Ziemnicka, K. (2022). Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism. https://doi.org/10.1177/20420188211066699

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.